Long-term survival of patients (pts) with advanced melanoma treated with ipilimumab with or without dacarbazine

被引：0
|
作者：
Hersh, E.
Weber, J.
Powderly, J.
Pavlik, A.
Nichol, G.
Yellin, M.
Cranmer, L.
Urba, W.
O'Day, S.
机构：
[1] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA
[2] Comprehens Melanoma Res Ctr, Tampa, FL USA
[3] Carolina BioOncol Inst, Hunterville, NC USA
[4] NYU, Med Ctr, New York, NY 10016 USA
[5] Medarex Inc, Bloomsbury, NJ USA
[6] Providence Portland Med Ctr, Portland, OR USA
[7] Angeles Clin, Res Inst, Santa Monica, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9038
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Disease control and long-term survival in chemotherapy-naive patients with advanced melanoma treated with ipilimumab (MDX-010) with or without dacarbazine
    Hersh, E. M.
    Weber, J. S.
    Powderly, J. D.
    Khan, K.
    Pavlick, A. C.
    Samlowski, W. E.
    O'Day, S. J.
    Nichol, G.
    Yellin, M. J.
    Cramner, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] LONG-TERM SURVIVAL OF PATIENTS WITH ADVANCED MELANOMA TREATED SECOND LINE WITH IPILIMUMAB
    Lee, D.
    Pericleous, L.
    Lebmeier, M.
    Winn, B.
    Batty, A.
    Nikoglou, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 370 - 370
  • [3] Long-term survival in advanced melanoma for patients treated with nivolumab plus ipilimumab in CheckMate 067.
    Hodi, F. Stephen
    Chiarion-Sileni, Vanna
    Lewis, Karl D.
    Grob, Jean-Jacques
    Rutkowski, Piotr
    Lao, Christopher D.
    Cowey, Charles Lance
    Schadendorf, Dirk
    Wagstaff, John
    Dummer, Reinhard
    Queirolo, Paola
    Smylie, Michael
    Butler, Marcus O.
    Hill, Andrew Graham
    Marquez-Rodas, Ivan
    Haanen, John B. A. G.
    Durani, Piyush
    Wang, Peter
    Wolchok, Jedd D.
    Larkin, James
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Long-term survival of patients with metastatic melanoma (MM) treated with dacarbazine (DTIC) or temozolomide (TMZ)
    Kim, C.
    Lee, C. W.
    Klasa, R.
    Shah, A.
    Savage, K. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Long-Term Survival in Patients With Advanced Melanoma
    van Not, Olivier J.
    van den Eertwegh, Alfons J. M.
    Jalving, Hilde
    Bloem, Manja
    Haanen, John B.
    van Rijn, Rozemarijn S.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Blank, Christian U.
    Boers-Sonderen, Marye J.
    de Groot J. W. B., Jan Willem
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Leeneman, Brenda
    Piersma, D.
    Stevense-den Boer, Marion
    van der Veldt, Astrid A. M.
    Vreugdenhil G., Gerard
    Wouters, Michel W. J. M.
    Blokx, Willeke A. M.
    Suijkerbuijk, Karijn P. M.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [6] IPILIMUMAB IMPROVES OVERALL SURVIVAL IN PATIENTS WITH PREVIOUSLY TREATED, ADVANCED MELANOMA: LONG-TERM SURVIVAL RESULTS FROM A PHASE III TRIAL
    Haanen, J. B.
    Hodi, F. S.
    O'Day, S. J.
    McDermott, D. F.
    Robert, C.
    Schadendorf, D.
    van den Eertwegh, A. J.
    Chen, T.
    Hoos, A.
    Urba, W. J.
    ANNALS OF ONCOLOGY, 2010, 21 : 402 - 402
  • [7] Overall Survival (OS) and New Patterns of Response in Patients (Pts) With Advanced Melanoma Treated With Ipilimumab
    O'Day, Steven
    Ibrahim, Ramy
    De Pril, Veerle
    Maio, Michele
    Sileni, Vanna Chiarion
    Gajewski, Thomas F.
    Pehamberger, Hubert
    Bondarenko, Igor N.
    Queirolo, Paola
    Lundgren, Lotta
    Mikhailov, Sergey
    Roman, Laslo
    Verschraegen, Claire
    Hoos, Axel
    Humphrey, Rachel
    Wolchok, Jedd
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 937 - 938
  • [8] LONG-TERM COMPLETE REMISSIONS IN PATIENTS WITH DISSEMINATED MELANOMA TREATED BY FOTEMUSTINE AND DACARBAZINE
    OLIVER, V
    ALIAGA, A
    LOPEZ, JJL
    PEREZ, E
    PONCHON, A
    BIZZARI, JP
    COUR, V
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (02) : 287 - 287
  • [9] The Ipilimumab Lesson in Melanoma: Achieving Long-Term Survival
    Delyon, Julie
    Maio, Michele
    Lebbe, Celeste
    SEMINARS IN ONCOLOGY, 2015, 42 (03) : 387 - 401
  • [10] Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors
    Ismail, Rawa K.
    Suijkerbuijk, Karijn P. M.
    de Boer, Anthonius
    van Dartel, Maaike
    Hilarius, Doranne L.
    Pasmooij, A. M. G.
    van Zeijl, Michiel C. T.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Blank, Christian U.
    Boers-Sonderen, Marye J.
    de Groot, Jan W. B.
    Haanen, John B. A. G.
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Piersma, Djura
    van Rijn, Rozemarijn S.
    van der Veldt, Astrid A. M.
    Vreugdenhil, Art
    Westgeest, Hans
    van den Eertwegh, Alfons J.
    Wouters, Michel W. J. M.
    MELANOMA RESEARCH, 2022, 32 (06) : 460 - 468
12345